2 days Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha

Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market.

Amgen (AMGN) · Biotech

11 hours Why Summit Therapeutics Stock Was a Winner TodayThe Motley Fool X

11 hours Why Viking Therapeutics Stock Plummeted After Soaring TodayThe Motley Fool X

14 hours Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

16 hours Gilead Science to Report Q3 Earnings: What’s in the Cards?Zacks X

22 hours This Beaten-Down Stock Could Soar by 354%, According to Wall StreetThe Motley Fool X

23 hours Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal X

2 days Buffett Still Building This Stake, Plus Huge Insider Buy in Biotech IPO24/7 Wall St. X

3 days Is Recursion Pharmaceuticals a Millionaire-Maker Stock?The Motley Fool X

4 days ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting DebacleInvestor's Business Daily X

4 days Analyst Report: AMGEN Inc.Yahoo Finance X

4 days Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHCYahoo Finance X

5 days Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars LoomInvestor's Business Daily X

5 days This High-Flying Stock Just Became a Better BuyThe Motley Fool X

5 days Amgen Inc. (AMGN) Q3 2024 Earnings Call TranscriptSeeking Alpha X

5 days Amgen Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

5 days Amgen (AMGN) Q3 2024 Earnings Call TranscriptThe Motley Fool X

5 days Why Guardant Health Stock Was the Picture of Health TodayThe Motley Fool X

6 days Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily X

6 days Amgen beats Q3 earnings estimates, raises full-year guidanceInvesting.com X

6 days Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Declines By 12.7%MarketBeat X

7 days Harmony Bio, The No. 1 Biotech Stock, Surges On Its ‘High Quality’ BeatInvestor's Business Daily X

7 days Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen.Investor's Business Daily X

1 week Regeneron to Report Q3 Earnings: What’s in the Offing?Zacks X

1 week Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings?Zacks X

1 week Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?Zacks X

1 week First American Bank Has $4.18 Million Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat X

1 week Zacks Research Forecasts Amgen’s Q1 Earnings (NASDAQ:AMGN)MarketBeat X

1 week Novo Holdings A S Has $3.52 Million Position in IO Biotech, Inc. (NASDAQ:IOBT)MarketBeat X

1 week Oncolytics Biotech Inc. (NASDAQ:ONCY) Sees Significant Increase in Short InterestMarketBeat X

1 week 3 Key Trends That Are Bullish for Recursion Pharmaceuticals StockThe Motley Fool X

1 week The Ultimate Biotech Stock to Buy With $50 Right NowThe Motley Fool X

1 week Legend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of “Buy” from AnalystsMarketBeat X

1 week U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small NamesSeeking Alpha X

2 weeks Amgen Inc. Declares Quarterly Dividend of $2.25 (NASDAQ:AMGN)MarketBeat X

2 weeks Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The ListSeeking Alpha X

2 weeks Why Intellia Therapeutics Stock Plummeted by 20% TodayThe Motley Fool X

2 weeks Why Viking Therapeutics Stock Soared by Nearly 21% on ThursdayThe Motley Fool X

2 weeks XBI: Biotech ETF Is A Must HaveSeeking Alpha X

2 weeks Zai Lab, A Top 6% Stock, Launched To A 16-Month High On Its ‘Impressive’ ResultsInvestor's Business Daily X

2 weeks Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug loomsMarketWatch X

2 weeks 5 Biotech Stocks Likely to Outperform as Industry Prospects Look BrightZacks X

2 weeks What sector do you think will be the next bubble?Reddit X

2 weeks 1 Brand-New Big Reason to Buy This Biotech Stock Right NowThe Motley Fool X

2 weeks Amgen Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks X

2 weeks Recursion Pharmaceuticals (RXRX): A Promising Small-Cap in Biotech InnovationInsider Monkey X

2 weeks Viridian Therapeutics (VRDN): A Small-Cap Biotech with Promising Clinical ResultsInsider Monkey X

2 weeks Mirum Pharmaceuticals (MIRM): A Small-Cap Biotech with Strong Sales GrowthInsider Monkey X

2 weeks Arvinas (ARVN): A Small-Cap Biotech with High Growth PotentialInsider Monkey X

2 weeks Allspring Global Investments Holdings LLC Sells 11,091 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X

2 weeks Legend Biotech (NASDAQ:LEGN) Shares Gap Up – Here’s WhyMarketBeat X